Literature DB >> 6886972

Time-dependent kinetics of lignocaine in the isolated perfused rat liver.

M S Lennard, G T Tucker, H F Woods.   

Abstract

The kinetics of lignocaine have been investigated in the isolated perfused rat liver preparation. After a low dose (0.3 mg) the drug was eliminated according to first-order kinetics, but after higher doses (7.5, 15.0 mg) and multiple doses (3 X 1.5 mg at 15 min intervals), nonlinear kinetics were observed, which appeared to show time dependence. This was not due to deterioration of the preparation nor was there any evidence of a hepatotoxic effect of lignocaine. The kinetics of lignocaine were also found to be sex-dependent since it was eliminated at a faster rate by livers from male rats compared to those from female rats. Exogenous MEGX (7.5 mg), the mono-N-deethylated metabolite of lignocaine, inhibited the elimination of parent drug (1.5 mg dose). However, evidence was obtained suggesting that a direct effect of this and other end-product metabolites may not be responsible for the observed changes in lignocaine kinetics with time when the compounds are produced endogenously. Studies of the hepatic binding of lignocaine in the preparation showed the presence of high affinity-low capacity and low affinity-high capacity binding sites, which may be the enzymes responsible for aromatic hydroxylation and N-deethylation of the drug, respectively. Further experiments supported the view that an intermediate product of lignocaine, related to the N-deethylation pathway, might be inhibiting its further metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886972     DOI: 10.1007/bf01061847

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  26 in total

1.  The continuous kinetic determination of p-nitroanisole O-demethylation in hemoglobin-free perfused rat liver.

Authors:  R G Thurman; D P Marazzo; L S Jones; F C Kauffman
Journal:  J Pharmacol Exp Ther       Date:  1977-05       Impact factor: 4.030

2.  Mixed function oxidation in perfused rat liver. The effect of aminopyrine on oxygen uptake.

Authors:  R G Thurman; R Scholz
Journal:  Eur J Biochem       Date:  1969-10

3.  The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver.

Authors:  G H Evans; G R Wilkinson; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

4.  Extraction and metabolism of lidocaine in rat liver.

Authors:  G Nyberg; B Karlén; I Hedlund; R Grundin; C von Bahr
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-02

5.  Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.

Authors:  P A Routledge; W W Stargel; G S Wagner; D G Shand
Journal:  Ann Intern Med       Date:  1980-11       Impact factor: 25.391

6.  Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.

Authors:  L F Prescott; K K Adjepon-Yamoah; R G Talbot
Journal:  Br Med J       Date:  1976-04-17

7.  Evidence for two catalytically different binding sites of liver microsomal cytochrome P-450: importance for species and sex differences in oxidation pattern of lidocaine.

Authors:  C von Bahr; I Hedlund; B Karlén; D Bäckström; H Grasdalen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-07

8.  Inhibition of hepatic gluconeogenesis by ethanol.

Authors:  H A Krebs; R A Freedland; R Hems; M Stubbs
Journal:  Biochem J       Date:  1969-03       Impact factor: 3.857

9.  The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite.

Authors:  J F Pritchard; D W Schneck; A H Hayes
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-02

10.  Gluconeogenesis in the perfused rat liver.

Authors:  R Hems; B D Ross; M N Berry; H A Krebs
Journal:  Biochem J       Date:  1966-11       Impact factor: 3.857

View more
  4 in total

1.  Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.

Authors:  G T Tucker; N D Bax; M S Lennard; S Al-Asady; H S Bharaj; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 2.  Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.

Authors:  C P Denaro; N L Benowitz
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

3.  The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects.

Authors:  A H Thomson; H L Elliott; A W Kelman; P A Meredith; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

4.  An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.

Authors:  K S Pang; J A Terrell; S D Nelson; K F Feuer; M J Clements; L Endrenyi
Journal:  J Pharmacokinet Biopharm       Date:  1986-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.